Parallel Advisors, LLC Rapt Therapeutics, Inc. Transaction History

Parallel Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	SELL	$15.89 - $40.87 $67,262 - $173,002	-4,233 Reduced 86.23%	676 $13,000
Q3 2020 Oct 27, 2020	BUY	$21.6 - $37.5 $9,482 - $16,462	439 Added 9.82%	4,909 $158,000
Q2 2020 Jul 16, 2020	BUY	$14.16 - $32.85 $63,295 - $146,839	4,470 New	4,470 $129,000

102

49M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $34.4M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.